| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/JCB.23009 |
| P698 | PubMed publication ID | 21328467 |
| P2093 | author name string | Fuu-Jen Tsai | |
| Chih-Hsin Tang | |||
| Chih-Yang Huang | |||
| Chang-Hai Tsai | |||
| Yueh-Min Lin | |||
| Chia-Hua Kuo | |||
| Tung-Yuan Lai | |||
| Li-Mien Chen | |||
| His-Hsien Hsu | |||
| Cheng-Chuan Su | |||
| P2860 | cites work | TGF-beta1 increases motility and alphavbeta3 integrin up-regulation via PI3K, Akt and NF-kappaB-dependent pathway in human chondrosarcoma cells | Q40025977 |
| RANKL acts directly on RANK-expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes | Q40050213 | ||
| Role of ICAM1 in invasion of human breast cancer cells | Q40445571 | ||
| Intercellular adhesion molecule-1. | Q40957917 | ||
| Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38. | Q42830960 | ||
| Fluid flow shear stress stimulates human osteoblast proliferation and differentiation through multiple interacting and competing signal transduction pathways. | Q44384607 | ||
| Inhibition of ICAM-1 gene expression, monocyte adhesion and cancer cell invasion by targeting IKK complex: molecular and functional study of novel alpha-methylene-gamma-butyrolactone derivatives. | Q44951928 | ||
| Molecular identification of a novel fibrinogen binding site on the first domain of ICAM-1 regulating leukocyte-endothelium bridging. | Q52523450 | ||
| IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain | Q22010650 | ||
| Activation of NF-kappaB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-kappaB-inducing kinase. Identification of a novel TRAF6 interaction motif | Q28138697 | ||
| Cancer statistics, 2001 | Q28189339 | ||
| Characterization of the intracellular domain of receptor activator of NF-kappaB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-kappab and c-Jun N-terminal kinase | Q28278061 | ||
| Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation | Q28302681 | ||
| Expression of RANKL/RANK/OPG in primary and metastatic human prostate cancer as markers of disease stage and functional regulation | Q28575953 | ||
| Osteoclast differentiation and activation | Q29547556 | ||
| Integrins in cancer: biological implications and therapeutic opportunities | Q29614536 | ||
| Cancer metastasis: building a framework | Q29616783 | ||
| Cancer statistics, 2005 | Q29617572 | ||
| Akt phosphorylation of p300 at Ser-1834 is essential for its histone acetyltransferase and transcriptional activity | Q33925258 | ||
| Treatment of non-small-cell lung cancer: state of the art and development of new biologic agents | Q35551162 | ||
| Bone-derived SDF-1 stimulates IL-6 release via CXCR4, ERK and NF-kappaB pathways and promotes osteoclastogenesis in human oral cancer cells | Q36838004 | ||
| Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease. | Q36860987 | ||
| Influence of simultaneous targeting of the bone morphogenetic protein pathway and RANK/RANKL axis in osteolytic prostate cancer lesion in bone | Q37131738 | ||
| Inhibitors targeting the LFA-1/ICAM-1 cell-adhesion interaction: design and mechanism of action | Q37264826 | ||
| Osteoprotegerin, vascular calcification and atherosclerosis | Q37310825 | ||
| Role of MAPK pathway oncoproteins in thyroid cancer pathogenesis and as drug targets | Q37397367 | ||
| ICAM-1 signaling in endothelial cells | Q37421151 | ||
| Cell adhesion molecules: role and clinical significance in cancer | Q37631589 | ||
| CTGF enhances the motility of breast cancer cells via an integrin-alphavbeta3-ERK1/2-dependent S100A4-upregulated pathway | Q38301101 | ||
| Involvement of matrix metalloproteinase-3 in CCL5/CCR5 pathway of chondrosarcomas metastasis. | Q39812550 | ||
| BMP-2 increases migration of human chondrosarcoma cells via PI3K/Akt pathway | Q39948230 | ||
| P433 | issue | 3 | |
| P921 | main subject | lung cancer | Q47912 |
| P304 | page(s) | 933-941 | |
| P577 | publication date | 2011-03-01 | |
| P1433 | published in | Journal of Cellular Biochemistry | Q6294917 |
| P1476 | title | RANKL increases migration of human lung cancer cells through intercellular adhesion molecule-1 up-regulation | |
| P478 | volume | 112 |
| Q36823687 | A prognostic signature of G(2) checkpoint function in melanoma cell lines |
| Q36562200 | Amphiregulin enhances intercellular adhesion molecule-1 expression and promotes tumor metastasis in human osteosarcoma |
| Q26863493 | Anti-RANKL therapy for bone tumours: Basic, pre-clinical and clinical evidences |
| Q35035922 | Apoptosis signal-regulating kinase 1 is involved in WISP-1-promoted cell motility in human oral squamous cell carcinoma cells |
| Q28397726 | Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: focus on the cancer hallmark of tumor angiogenesis |
| Q36759878 | Basigin-2 upregulated by receptor activator of NF-κB ligand enhances lung cancer-induced osteolytic lesions |
| Q35995710 | C-Src-mediated RANKL-induced breast cancer cell migration by activation of the ERK and Akt pathway |
| Q90278559 | Caveolin‑1 enhances RANKL‑induced gastric cancer cell migration |
| Q23917422 | Cell permeability, migration, and reactive oxygen species induced by multiwalled carbon nanotubes in human microvascular endothelial cells |
| Q44972307 | Cell permeability, migration, and reactive oxygen species induced by multiwalled carbon nanotubes in human microvascular endothelial cells |
| Q35609448 | Chronic stress, sympathetic activation and skeletal metastasis of breast cancer cells |
| Q61797344 | Decidual RANKL/RANK interaction promotes the residence and polarization of TGF-β1-producing regulatory γδ T cells |
| Q93012639 | Dynamic changes of Receptor activator of nuclear factor-κB expression in Circulating Tumor Cells during Denosumab predict treatment effectiveness in Metastatic Breast Cancer |
| Q37441693 | Effects of RANKL-Targeted Therapy in Immunity and Cancer |
| Q41553064 | Fractalkine/CX3CL1 induced intercellular adhesion molecule-1-dependent tumor metastasis through the CX3CR1/PI3K/Akt/NF-κB pathway in human osteosarcoma. |
| Q90442956 | Harnessing the versatile role of OPG in bone oncology: counterbalancing RANKL and TRAIL signaling and beyond |
| Q53414860 | High-dose ionizing radiation-induced hematotoxicity and metastasis in mice model. |
| Q37525535 | Loss of connectivity in cancer co-expression networks. |
| Q35839536 | Proinflammatory adhesion molecules facilitate polychlorinated biphenyl-mediated enhancement of brain metastasis formation |
| Q47140509 | RANK rewires energy homeostasis in lung cancer cells and drives primary lung cancer. |
| Q26747442 | RANK-RANKL signalling in cancer |
| Q34277337 | RANKL promotes migration and invasion of hepatocellular carcinoma cells via NF-κB-mediated epithelial-mesenchymal transition |
| Q92612736 | RANKL/RANK promotes the migration of gastric cancer cells by interacting with EGFR |
| Q49371326 | Rankl expression predicts poor prognosis in gastric cancer patients: results from a retrospective and single-center analysis |
| Q39212231 | Riboflavin at high doses enhances lung cancer cell proliferation, invasion, and migration |
| Q37337499 | Role of sympathetic nerves in the establishment of metastatic breast cancer cells in bone |
| Q39375981 | Saikosaponin-d Enhances the Anticancer Potency of TNF-α via Overcoming Its Undesirable Response of Activating NF-Kappa B Signalling in Cancer Cells |
| Q34995664 | Selenoglycoproteins attenuate adhesion of tumor cells to the brain microvascular endothelium via a process involving NF-κB activation |
| Q44097876 | Supplementation with selenium-enriched yeast attenuates brain metastatic growth |
| Q37535480 | Syk/JNK/AP-1 signaling pathway mediates interleukin-6-promoted cell migration in oral squamous cell carcinoma |
| Q33759713 | Targeted treatments of bone metastases in patients with lung cancer |
| Q26849690 | Targeting RANKL in metastasis |
| Q98771227 | Targeting the RANKL/RANK/OPG Axis for Cancer Therapy |
| Q36356112 | The E3 ubiquitin ligase Cbl-b improves the prognosis of RANK positive breast cancer patients by inhibiting RANKL-induced cell migration and metastasis. |
| Q41200607 | The RANK/RANKL/OPG system in tumorigenesis and metastasis of cancer stem cell: potential targets for anticancer therapy. |
| Q26799134 | Therapeutic Potential of Denosumab in Patients With Lung Cancer: Beyond Prevention of Skeletal Complications |
Search more.